Knockout of G protein-coupled receptor 68 (GPR68) or inhibition of the IL-6/STAT3 pathway in MSCs has been shown to suppress in situ OS growth and extend the lifespan after tumor xenograft transplantation. Here, STAT3 is linked to neoplasm.